Computation and collaboration lead to significant advance in malaria

August 14, 2014
Credit: CDC

Researchers led by Baylor College of Medicine have developed a new computational method to study the function of disease-causing genes, starting with an important new discovery about a gene associated with malaria – one of the biggest global health burdens.

The work published today in the current issue of the journal Cell includes collaborators comprised of computational and evolutionary biologists and leading malaria experts from Baylor, Columbia University Medical Center, Princeton University, Pennsylvania State University and the National Institute of Allergy and Infectious Diseases (NIAID).

"Today, rapidly falling costs means that high throughput sequencing projects are revealing the entire gene sequences of ever more species, but the biological functions of most of these genes remain unknown," said Dr. Olivier Lichtarge, professor of molecular and human genetics and director of the Computational and Integrative Biomedical Research Center at Baylor and senior author of the report. "To address this problem, our lab has developed new methods to predict gene and protein functions."

Dr. Andreas Martin Lisewski, an instructor in Lichtarge's lab at Baylor, served as the leading author on the report.

The researchers came up with a that allows biological information to literally flow from gene to gene across a massive network across many genomes, known as the "supergenomic" network.

"The network connects millions of genes from hundreds of species based on their interactions within the organism or based on their ancestral relations between different species," said Lisewski. "Normally, computing the flow of functional information would be costly and slow, but we developed a compression method that reduces this gigantic network into one that is much smaller and now computationally tractable. The surprise is that these biological networks are compressible much like digital data in today's computers."

To test their method, the researchers looked at functional predictions of a protozoan parasite known to cause the most severe form of malaria in humans – Plasmodium falciparum. While it has been more than 10 years since the genome of this parasite was fully sequenced, still too little is known about the function for most of its genes.

Every year, malaria affects more than 200 million people and contributes to nearly 1 million deaths worldwide.

"To better understand this disease, we need to identify more functions of the parasite's genes. This understanding may eventually help us to stem the rise of drug-resistant malaria, such as the emerging resistance to artemisinins," said Lisewski.

Artemisinins are a family of drugs that currently form the frontline treatment against Plasmodium falciparum malaria. Artemisinin was originally isolated as an extract from a traditional Chinese herbal remedy, and while it is still highly effective against malaria in patients, the mechanism of action has been unclear. A loss of artemisinin's antimalarial effectiveness due to genetic resistance would have devastating global health consequences.

The researchers honed in on the parasite protein EXP1 that was known to be essential to the but for which there were no details on its function.

Using the network, they showed that this protein enables the parasite to detoxify the main metabolic byproducts it creates in red blood cells. They also demonstrated that it has a direct role in drug action and susceptibility to artesunate, an important member of the artemisinin drug family.

"Through this multi-year collaborative effort, we now have an improved understanding of the protective molecular mechanisms of the parasite and its drug susceptibility to artesunate. As we are witnessing a rise of resistance to artemisinins, these results may help finding new pathways to successor drugs," said Lichtarge.

Explore further: Major breakthrough in quest for new malaria drugs

Related Stories

Major breakthrough in quest for new malaria drugs

July 17, 2014
Victorian scientists have made a major breakthrough in the race to find new drugs to fight malaria, one of the world's most devastating diseases.

One route to malaria drug resistance found

July 24, 2014
Researchers have uncovered a way the malaria parasite becomes resistant to an investigational drug. The discovery, at Washington University School of Medicine in St. Louis, also is relevant for other infectious diseases including ...

Drug-resistant malaria has spread to critical border regions of Southeast Asia

July 30, 2014
Drug-resistant malaria parasites have spread to critical border regions of Southeast Asia, seriously threatening global malaria control and elimination programmes, according to a study published in the New England Journal ...

New compound blocks 'gatekeeper' enzyme to kill malaria

July 1, 2014
Melbourne researchers are homing in on a new target for malaria treatment, after developing a compound that blocks the action of a key 'gatekeeper' enzyme essential for malaria parasite survival.

Researchers identify genetic marker of resistance to key malaria drug

December 18, 2013
An international team of researchers has discovered a way to identify, at a molecular level, malaria-causing Plasmodium falciparum parasites that are resistant to artemisinin, the key drug for treating this disease. The research ...

Recommended for you

A sodium surprise: Engineers find unexpected result during cardiac research

July 20, 2017
Irregular heartbeat—or arrhythmia—can have sudden and often fatal consequences. A biomedical engineering team at Washington University in St. Louis examining molecular behavior in cardiac tissue recently made a surprising ...

Want to win at sports? Take a cue from these mighty mice

July 20, 2017
As student athletes hit training fields this summer to gain the competitive edge, a new study shows how the experiences of a tiny mouse can put them on the path to winning.

Engineered liver tissue expands after transplant

July 19, 2017
Many diseases, including cirrhosis and hepatitis, can lead to liver failure. More than 17,000 Americans suffering from these diseases are now waiting for liver transplants, but significantly fewer livers are available.

Lunatic Fringe gene plays key role in the renewable brain

July 19, 2017
The discovery that the brain can generate new cells - about 700 new neurons each day - has triggered investigations to uncover how this process is regulated. Researchers at Baylor College of Medicine and Jan and Dan Duncan ...

'Smart' robot technology could give stroke rehab a boost

July 19, 2017
Scientists say they have developed a "smart" robotic harness that might make it easier for people to learn to walk again after a stroke or spinal cord injury.

New animal models for hepatitis C could pave the way for a vaccine

July 19, 2017
They say that an ounce of prevention is worth a pound of cure. In the case of hepatitis C—a disease that affects nearly 71 million people worldwide, causing cirrhosis and liver cancer if left untreated—it might be worth ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.